Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Friday, December 14, 2018 · 471,087,643 Articles · 3+ Million Readers

Brazil, Russia And India Offer The Best Opportunities In The Musculoskeletal Drugs Markets To 2020

Growth/share Chart On Musculoskeletal Drugs Market By Country

Growth/share Chart On Musculoskeletal Drugs Market By Country

LONDON, GREATER LONDON, UK, October 13, 2017 / -- Three of the BRICs (Brazil, Russia and India) have high recent and forecast market growth rates for musculoskeletal drugs and so will move up the table of consumer countries for these drugs. Currently the largest markets for drugs that treat diseases such as arthritis, osteoporosis, osteomalacia, carpal tunnel syndrome and muscular dystrophy are in countries such as the USA and Japan and China; the USA's market is and will remain vastly bigger than any other, but the three BRIC markets are beginning to catch up with Japan and China. For example, while India's market was only two-thirds of Japan's in 2016, by 2020 its sales will be equal to 84% of the Japanese sales. Again, Again, Brazil's market was only half as big as China’s in 2016 but will be worth nearly 60% of that market by 2020.
Many musculosketal disorders are incurable so that patients will take these pain- and inflammation-reducing drugs either continuously or periodically for life. As their incidence is age-related, the increase in the size of the aging population is one factor driving the growth of this market. Other factors are increasing global obesity and stress levels.
Globally, the market for musculosketal drugs equates to about 14% of the pharma total and is growing at over 7% year on year. This compares with growth rates around 5% for pharmaceuticals in general.
The benefits of growth in these markets will be widely distributed. Although the leading manufacturers of these drugs are the Swiss company Hoffmann-La Roche, the British GlaxoSmithKline and the USA’s Pfizer, the top ten pharma companies together only account for around 10% of global sales. Small pharma companies in the emerging economies and generic drugs account for the majority of sales of these products.

Where to Learn More
Read Musculoskeletal Disorders Drugs Market Global Report 2017 from The Business Research Company for information on the following:
Markets Covered: Rheumatoid Arthritis, Muscle Relaxants, Others
Companies Mentioned: AbbVie, Amgen, Johnson & Johnson, F. Hoffmann-La Roche Ltd, and Pfizer Inc.
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Musculoskeletal Disorders Drugs Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Interested to know more? Here is a full scope of Biologics and Pharmaceutical Drugs Market reports to explore:
1. Biologics Market Global Report 2017 (
2. Anti-infective Drugs Market Global Report 2017 (
3. Cardiovascular Drugs Market Global Report 2017 (
4. Central Nervous System Drugs Market Global Report 2017 (
5. Dermatology Drugs Market Global Report 2017 (
6. Genito-Urinary Drugs Market Global Report 2017 (
7. Hematology Drugs Market Global Report 2017 (
8. Metabolic Disorder Drugs Market Global Report 2017 (
9. Musculoskeletal Disorders Drugs Market Global Report 2017 (
10. Ophthalmology Drugs Market Global Report 2017 (
11. Gastrointestinal Drugs Market Global Report 2017 (
12. Respiratory Drugs Market Global Report 2017 (
13. Oncology Drugs Market Global Report 2017 (

About The Business Research Company
Visit The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has research professionals at its office in the UK, India, and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. The Business Research Company’s management have more than 20 years of varied business research experience. They have delivered hundreds of research projects to the senior management of some of the world’s largest organizations. The Business Research Company’s Consultant have master’s qualifications from top institutes and include MBAs, MSCs, CFAs and CAs. The Business Research Company’s Consultants gain training and qualifications from the market Research Society and are trained in advanced research practices, techniques, and ethics.

Oliver Guirdham
The Business Research Company
+44 744 3439350
email us here

Powered by EIN Presswire

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release